Previous close | 368.18 |
Open | 364.22 |
Bid | 352.77 x 800 |
Ask | 360.79 x 800 |
Day's range | 358.89 - 370.00 |
52-week range | 310.42 - 415.73 |
Volume | |
Avg. volume | 545,301 |
Market cap | 26.385B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 47.61 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.80 (0.22%) |
Ex-dividend date | 31 Jul 2024 |
1y target est | N/A |
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2024 and updated full-year 2024 financial guidance.
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 25, 2024, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2024, at 1:05 PM ET.